🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Metabolomic Profiling of Patients With Traumatic Brain Injury

Recruitingn/aAges 18 Years - 65 YearsAllDr Abdurrahman Yurtaslan Ankara Oncology Training…
NCT07292766 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Traumatic Brain Injury (TBI) is a significant cause of mortality and morbidity worldwide. However, the literature on determining its severity and predicting prognosis is insufficient. This study aimed to examine the differences in metabolite levels between trauma patients with severe TBI and orthopedic trauma patients without brain injury.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Ages 18-65 * Patients diagnosed with severe TBI clinically or according to National Institute for Health and Care Excellence (NICE) criteria (including post-traumatic imaging) * Patients with non-TBI orthopedic or multitrauma Exclusion Criteria: * Presence of brain pathology in the pre-trauma period * Patient with chronic subdural hematoma
💊

What it tests

  • Not listed
📍

Where

1 site
Aksaray University
Aksaray, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy